Chen, Zhu
Ruijin Hospital,
China
2025 Rank: 15726
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 553 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15726 | 16400 |
| Total Cites | 46031 | 51973 |
| H-index | 92 | 99 |
| Hm-index | 22 | 24 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 466 | 467 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1577 | 1705 |
| Number of Single+First+Last Authored Papers | 113 | 113 |
| Total Cites to Single+First+Last Authored Papers | 10277 | 11245 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 37355 | 40707 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.28 |
| Self-Citation Percentage |
11.43%
|
|
Chen, Zhu
Ruijin Hospital,
China
2024 Rank: 15528
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 558 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15528 | 15849 |
| Total Cites | 43788 | 49585 |
| H-index | 90 | 97 |
| Hm-index | 21 | 23 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 444 | 445 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1528 | 1656 |
| Number of Single+First+Last Authored Papers | 113 | 113 |
| Total Cites to Single+First+Last Authored Papers | 9810 | 10770 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 35499 | 38775 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.28 |
| Self-Citation Percentage |
11.69%
|
|
Chen, Zhu
Ruijin Hospital,
China
2023 Rank: 15113
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 560 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15113 | 15731 |
| Total Cites | 41599 | 47198 |
| H-index | 88 | 94 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 415 | 416 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1478 | 1606 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 9415 | 10344 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 33633 | 36803 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.28 |
| Self-Citation Percentage |
11.86%
|
|
Chen, Zhu
Guangdong Ocean University,
China
2022 Rank: 14671
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 556 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14671 | 15243 |
| Total Cites | 38997 | 44419 |
| H-index | 86 | 92 |
| Hm-index | 20 | 22 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 372 | 373 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1411 | 1539 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 8872 | 9795 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 31406 | 34440 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.29 |
| Self-Citation Percentage |
12.21%
|
|
Chen, Zhu
Shanghai Jiao Tong University School of Medicine,
China
2021 Rank: 14363
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 546 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14363 | 14741 |
| Total Cites | 37257 | 42490 |
| H-index | 84 | 91 |
| Hm-index | 20 | 22 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 356 | 357 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1375 | 1502 |
| Number of Single+First+Last Authored Papers | 114 | 114 |
| Total Cites to Single+First+Last Authored Papers | 8630 | 9529 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 29909 | 32823 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.29 |
| Self-Citation Percentage |
12.32%
|
|
Chen, Zhu
Ruijin Hospital,
China
2020 Rank: 18011
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 656 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18011 | 18683 |
| Total Cites | 30187 | 34676 |
| H-index | 77 | 84 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 300 | 301 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 841 | 914 |
| Number of Single+First+Last Authored Papers | 109 | 109 |
| Total Cites to Single+First+Last Authored Papers | 7521 | 8330 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 23843 | 26329 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.32 |
| Self-Citation Percentage |
12.95%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.